Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands

被引:10
作者
Vos, Cornelis F. [1 ,2 ]
Aarnoutse, Rob E. [3 ]
Op de Coul, Marijke J. M. [4 ]
Spijker, Jan [4 ,5 ]
Groothedde-Kuyvenhoven, Mascha M. [6 ,7 ]
Mihaescu, Raluca [8 ]
Wessels-Basten, Sonja J. W. [8 ]
Rovers, Jordy J. E. [9 ]
ter Hark, Sophie E. [1 ,2 ]
Schene, Aart H. [1 ,2 ]
Hulscher, Marlies E. J. L. [10 ]
Janzing, Joost G. E. [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Reinier Postlaan 10, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pharm Radboud Inst Hlth Sci, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Nijmegen, Netherlands
[5] Pro Persona, Nijmegen, Netherlands
[6] Deventer Hosp, Deventer, Netherlands
[7] Dimence Grp, Deventer, Netherlands
[8] Catharina Hosp, Eindhoven, Netherlands
[9] Vincent van Gogh Inst Psychiat, Venray, Netherlands
[10] Radboud Univ Nijmegen, Sci Ctr Qual Hlthcare, Med Ctr, Nijmegen, Netherlands
关键词
Antidepressant agents; Clinical practice guidelines; Qualitative approach; Major depressive disorder; Tricyclic antidepressants; GUIDELINES;
D O I
10.1186/s12888-021-03490-x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Traditionally tricyclic antidepressants (TCAs) have an important place in treatment of major depressive disorder (MDD). Today, often other antidepressant medications are considered as first step in the pharmacological treatment of MDD, mainly because they are associated with less adverse effects, whereby the position of TCAs appears unclear. In this study we aimed to examine the current practice of TCAs in treatment of unipolar MDD. Methods A mixed methods approach was applied. First, a selection of leading international and national guidelines was reviewed. Second, actual TCA prescription was examined by analyzing health records of 75 MDD patients treated with the TCAs nortriptyline, clomipramine or imipramine in different centers in the Netherlands. Third, promotors and barriers influencing the choice for TCAs and dosing strategies were explored using semi-structured interviews with 24 Dutch psychiatrists. Results Clinical practice guidelines were sometimes indirective and inconsistent with each other. Health records revealed that most patients (71%) attained therapeutic plasma concentrations within two months of TCA use. Patients who achieved therapeutic plasma concentrations reached them on average after 19.6 days (SD 10.9). Both health records and interviews indicated that therapeutic nortriptyline concentrations were attained faster compared to other TCAs. Various factors were identified influencing the choice for TCAs and dosing by psychiatrists. Conclusions Guideline recommendations and clinical practice regarding TCA prescription for MDD vary. To increase consistency in clinical practice we recommend development of an up-to-date guideline integrating selection and dosing of TCAs, including the roles of therapeutic drug monitoring and pharmacogenetics. Such a guideline is currently lacking and would contribute to optimal TCA treatment, whereby efficacy and tolerability may be increased.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The association of oxytocin with major depressive disorder: role of confounding effects of antidepressants
    Xie, Shiyi
    Hu, Yan
    Fang, Li
    Chen, Shijia
    Botchway, Benson O. A.
    Tan, Xiaoning
    Fang, Marong
    Hu, Zhiying
    REVIEWS IN THE NEUROSCIENCES, 2022, 33 (01) : 59 - 77
  • [22] Mild manic symptoms are associated with poor response to antidepressants in major depressive disorder
    Smith, D.
    BIPOLAR DISORDERS, 2007, 9 : 98 - 99
  • [23] Application and Evaluation of Neuromodulation in Major Depressive Disorder
    Li, Yu-Qing
    Jie, Hui-Cong
    Guo, Jiang-Zi-Hui
    Liu, Tiao-Tiao
    Zheng, Xu-Yuan
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2025, 52 (03) : 681 - 690
  • [24] Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder
    Jung, Woo-Young
    Jang, Sae-Heon
    Kim, Sung-Gon
    Jae, Young-Myo
    Kong, Bo-Geum
    Kim, Ho-Chan
    Choe, Byeong-Moo
    Kim, Jeong-Gee
    Kim, Choong-Rak
    PSYCHIATRY INVESTIGATION, 2016, 13 (04) : 440 - 446
  • [25] Antidepressants account for the causal effect of major depressive disorder on type 2 diabetes
    Baranova, Ancha
    Liu, Dongming
    Sun, Wenxi
    Xu, Chenxin
    Chen, Miao
    Cao, Hongbao
    Zhang, Fuquan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2025, 136
  • [26] Are antidepressants equally effective in the long-term treatment of major depressive disorder?
    Buoli, Massimiliano
    Melter, Claudia Cumerlato
    Caldiroli, Alice
    Altamura, A. Carlo
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2015, 30 (01) : 21 - 27
  • [27] Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
    Fontana, Andrea
    Manchia, Mirko
    Panebianco, Concetta
    Paribello, Pasquale
    Arzedi, Carlo
    Cossu, Eleonora
    Garzilli, Mario
    Montis, Maria Antonietta
    Mura, Andrea
    Pisanu, Claudia
    Congiu, Donatella
    Copetti, Massimiliano
    Pinna, Federica
    Carpiniello, Bernardo
    Squassina, Alessio
    Pazienza, Valerio
    BIOMEDICINES, 2020, 8 (09)
  • [28] Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder
    Shelton, Richard C.
    Papakostas, George I.
    ACTA PSYCHIATRICA SCANDINAVICA, 2008, 117 (04) : 253 - 259
  • [29] A review of current evidence for vilazodone in major depressive disorder
    Wang, Sheng-Min
    Han, Changsu
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Pae, Chi-Un
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 (03) : 160 - 169
  • [30] Emotion Differentiation in Current and Remitted Major Depressive Disorder
    Thompson, Renee J.
    Liu, Daphne Y.
    Sudit, Ella
    Boden, Matt
    FRONTIERS IN PSYCHOLOGY, 2021, 12